|Audit||Compensation and Management Development||Nominating and Corporate Governance|
|Lewis T. "Rusty" Williams, M.D., Ph.D.|
|Franklin M. Berger, CFA|
Mr. Nicholson has served as a member of our board of directors since May 2017. Mr. Nicholson served as President and Chief Executive Officer of XTuit Pharmaceuticals, Inc., from September 2015 to October 2016. From May 2008 to March 2015, Mr. Nicholson served at Pfizer Inc. as President, Pfizer Oncology. Prior to joining Pfizer, Mr. Nicholson worked at Eli Lilly and Company where he held roles of increasing responsibility, most recently as the Global Oncology Platform Leader. Mr. Nicholson currently serves on the board of directors of Tesaro, Inc., a public pharmaceutical company. Mr. Nicholson received a B.S. in Pharmacy from the University of North Carolina at Chapel Hill and an M.B.A. from the University of South Carolina.
|Sheila Gujrathi, M.D.|
|Peder K. Jensen, M.D.|
|Mark D. McDade|
|William R. Ringo|